Does multivitamin supplementation prevent infections in healthy elderly subjects? A controlled trial.

We performed a double blind randomized study in order to assess the efficacy of a multivitamin supplement for the prevention of common infections in healthy elderly subjects. Non-institutionalized, independent subjects over 60 years of age, living in the Nevers area (central France) were recruited by announcements and randomly assigned to a treatment or a placebo group. The treatment or placebo tablets were to be taken daily for 4 months. The principal criterion of response was the incidence of infections, as recorded from a detailed questionnaire presented at entrance, in the middle (2 months) and at the end (4 months) of the study. Blood samples were taken at the entrance in the study and after two and four months in order to monitor vitamin status. No significant difference was found between the two groups for the incidence of infections. In fact the observed incidences during the two two-month periods were higher in the treatment (0.38 and 0.21) than in the placebo group (0.29 and 0.13). After two months and after four months of supplementation, blood vitamin indicators of the subjects were significantly higher in the treatment than in the placebo group for vitamins B1, B2, B6, E and folates (p < 0.001). The improvement of the vitamin C status was slightly higher in the treatment than in the placebo group. For vitamin A status, the evolution was similar in the two groups. In conclusion, short-term supplementation of healthy elderly subjects with the investigated supplement is not likely to afford a meaningful protection against common infections.

RCT Entities:   Population Interventions Outcomes